Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151547 | SCV000199678 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Lys64Arg in Exon 03 of NEBL: This variant is not expected to have clinical sig nificance because it has been identified in 2.4% (91/3734) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs71578975). |
Labcorp Genetics |
RCV000475502 | SCV000563543 | benign | Primary dilated cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000151547 | SCV000739901 | likely benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001682865 | SCV001897048 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000151547 | SCV004038158 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001682865 | SCV005227072 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003917477 | SCV004728183 | benign | NEBL-related disorder | 2019-04-11 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |